The efficiency and safety of indomethacin spray for the pain of oral mucositis in patients receiving chemotherapy.

The efficiency and safety of indomethacin spray for the pain of oral mucositis in patients receiving chemotherapy. - The efficiency of indomethacin spray for the pain of oral mucositis in patients receiving chemotherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015816

Enrollment

Registered

2014-12-05

Start date

2015-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The pain of chemotherapy induced oral mucositis

Interventions

Indomethacin spray

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patients with oral mucositis pain, and the doctor in charge judged use of indomethacin spray to be useful in pain control

Exclusion criteria

Exclusion criteria: 1) Patient having serious comorbidities (a liver disease, renal disease, a heart trouble, blood disorder or metabolic disease). 2) A patient planning the use of the clinical experimental medicine or using. 3) The patient who is contraindicated to NSAIDs

Design outcomes

Primary

Measure	Time frame
Analgesic effect of indomethacin spray and placebo for chemotherapy induced oral mucositis.	—

Countries

Japan

Contacts

Public ContactHironobu Hata

Hokkkaido cancer center Department of dental surgery

hatahiro@sap-cc.go.jp011-811-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026